ClinicalTrials.Veeva

Menu

Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use

K

Kenneth Peters, MD

Status

Completed

Conditions

Stress Urinary Incontinence

Treatments

Procedure: Muscle Biopsy
Biological: Injection of autologous stem cells

Study type

Interventional

Funder types

Other

Identifiers

NCT01648491
2011-204

Details and patient eligibility

About

Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.

Full description

Autologous stem cells will be obtained from the subject by needle biopsy, sent to a lab for multiplication and after about 6 weeks time will be injected into the subjects urethra.

Enrollment

1 patient

Sex

Male

Ages

78 to 82 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • urinary incontinence
  • failed urinary incontinence (UI) treatments

Exclusion criteria

  • does not meet inclusion criteria, gender and age limit

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1 participants in 1 patient group

Stem Cell treatment
Experimental group
Description:
Muscle Biopsy and Injection of autologous stem cells
Treatment:
Procedure: Muscle Biopsy
Biological: Injection of autologous stem cells

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems